Abbott Laboratories (NYSE: ABT) is a US-based healthcare company. It works in the discovery, development, manufacture and marketing of pharmaceuticals, vaccines and medical products. In June 2014 it acquired Russian company Veropharm for up to $495 million, and in July 2014 it sold its branded generics business to US generics major Mylan for $5.3 billion.